Show simple item record

dc.contributor.authorAlidadiyani, N
dc.contributor.authorSalehi, R
dc.contributor.authorGhaderi, S
dc.contributor.authorSamadi, N
dc.contributor.authorDavaran, S
dc.date.accessioned2018-08-26T07:30:37Z
dc.date.available2018-08-26T07:30:37Z
dc.date.issued2016
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/47158
dc.description.abstractIn this study, the ability of methotrexate (MTX)-loaded stimuli-responsive novel silica nanocomposites (MSNs) (with mean diameter of +/- 60 nm) in the induction of apoptosis, and change in the Bax/Bcl-2 mRNA levels, were investigated. MTT assay and RT -PCR analysis were performed on MDA-MB-231 breast cancer cells, to evaluate their anti-proliferative, apoptotic and anti-apoptotic effects. MTX-loaded MSNs caused marked decrease in the percentage of viable cells, with a significant down-regulation in the level of expression of the anti-apoptotic gene (Bcl-2), and up-regulation in the apoptotic gene (Bax). MTX-loaded MSNs increased the efficacy of the chemotherapeutic agents in the inhibition of cell proliferation and induction of apoptosis.
dc.language.isoEnglish
dc.relation.ispartofARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY
dc.subjectBax
dc.subjectBcl-2
dc.subjectbiocompatible polymer
dc.subjectmethotrexate
dc.subjectBak
dc.subjectdrug delivery
dc.subjectnanomedicine
dc.subjectmesoporous silica nanoparticles
dc.subjectMDA-MB-231 breast cancer cell line
dc.titleSynergistic antiproliferative effects of methotrexate-loaded smart silica nanocomposites in MDA-MB-231 breast cancer cells
dc.typeArticle
dc.citation.volume44
dc.citation.issue2
dc.citation.spage603
dc.citation.epage609
dc.citation.indexWeb of science
dc.identifier.DOIhttps://doi.org/10.3109/21691401.2014.975235


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record